Question
To ask the Secretary of State for Health and Social Care, whether he has issued guidance to clinical commissioning groups and general practitioners on the use of epinephrine auto-injectors; and if he will make a statement.
Answered on
11 October 2018
The Department is working very closely with all the manufacturers of adrenaline auto-injectors, the Medicines and Healthcare Regulatory products Regulatory Agency, NHS England, and others to try to resolve these issues and improve the situation as quickly as possible. The overall supply situation is expected to improve by the end of 2018.
We issued comprehensive guidance on 28 September 2018, with input from National Health Service allergy experts. The guidance was cascaded to general practitioners, clinical commissioning groups and other healthcare professionals to help explain the issue and to advise on clinical and supply management during this time.